Syngene International (BOM:539268) EPS (Basic): ₹7.88 (TTM As of Mar. 2026)


BOM:539268 Syngene International Ltd BOM:539268
81 GF Score
Price ₹442.95
GF Value ₹788.42
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Syngene International EPS (Basic)?

Syngene International BOM:539268 +1.57% 81 EPS (Basic) is ₹7.88 as of Mar. 2026. GuruFocus rates BOM:539268 with a GF Score™ of 81/100 and a GF Value™ of ₹788.42 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Syngene International's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was ₹3.68. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹7.88.

Syngene International's EPS (Diluted) for the three months ended in Mar. 2026 was ₹3.67. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹7.86.

Syngene International's EPS without NRI for the three months ended in Mar. 2026 was ₹3.78. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 9.73.

During the past 12 months, Syngene International's average EPS without NRIGrowth Rate was -20.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was -6.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 1.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Syngene International's highest 3-Year average EPS without NRI Growth Rate was 62.70% per year. The lowest was -6.60% per year. And the median was 10.50% per year.

Syngene International  (BOM:539268) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Syngene International EPS (Basic) Related Terms

Syngene International EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Syngene International's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syngene International EPS (Basic) Chart

Syngene International Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.94 11.59 12.71 12.35 7.87

Syngene International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.56 2.16 1.67 0.37 3.68
BOM:539268
81GF Score
Syngene International Ltd BOM:539268
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Syngene International EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Syngene International's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(3167-0)/402.414
=7.87

Syngene International's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1479-0)/401.902
=3.68

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹7.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹7.88 mean?
Syngene International (BOM:539268) has a EPS (Basic) of ₹7.88 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Syngene International and its competitors.
Is Syngene International's EPS (Basic) too high?
Syngene International's current EPS (Basic) is ₹7.88. Overall, Syngene International has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Syngene International's EPS (Basic) compare to TMO and DHR?
Syngene International's EPS (Basic) of ₹7.88 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Diagnostics & Research company?
A good EPS (Basic) depends on the Medical Diagnostics & Research industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Syngene International and its competitors. Syngene International's current EPS (Basic) is ₹7.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Syngene International stock overvalued right now?
Based on GuruFocus' analysis, Syngene International (BOM:539268) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹788.42, compared to a current price of ₹442.95 — trading 43.8% below its estimated fair value. The current EPS (Basic) is ₹7.88. Syngene International's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Syngene International (BOM:539268), the current EPS (Basic) is ₹7.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Syngene International (BOM:539268) Overvalued in 2026?

Based on GuruFocus' analysis, Syngene International stock appears to be undervalued. The current stock price of ₹442.95 is trading 43.8% below its estimated GF Value™ of ₹788.42. GuruFocus considers Syngene International to be Significantly Undervalued.

Key valuation signals for BOM:539268:

  • EPS (Basic): ₹7.88
  • GF Value™: ₹788.42 vs. price of ₹442.95 (43.8% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the BOM:539268 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Syngene International Business Description

Other Exchanges SYNGENE:India
Address Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The Company is engaged in a single operating segment of providing contract research and manufacturing services. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the USA. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.
81GF Score

Get the complete analysis for BOM:539268

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹442.95
Price
₹788.42
GF Value